[HTML][HTML] MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition

Y Zhuang, J Dai, Y Wang, H Zhang, X Li… - American journal of …, 2016 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease involving pulmonary injury
associated with tissue repair, dysfunction and fibrosis. Recent studies indicate that some …

[HTML][HTML] MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1

Y Zhuang, J Dai, Y Wang, H Zhang, X Li… - American journal of …, 2016 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease involving pulmonary injury
associated with tissue repair, dysfunction and fibrosis. MicroRNAs (miRNAs), as gene …

miR‑320a‑3P alleviates the epithelial‑mesenchymal transition of A549 cells by activation of STAT3/SMAD3 signaling in a pulmonary fibrosis model

X Wang, J Wang, G Huang, Y Li… - Molecular Medicine …, 2021 - spandidos-publications.com
Pulmonary fibrosis (PF) is a common, chronic and incurable lung disease, in which the lungs
become scarred over time. MicroRNAs (miRNAs/miRs) serve key roles in various biological …

The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis

C Liang, X Li, L Zhang, D Cui, X Quan… - … and Molecular Pathology, 2015 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …

miR-130b-3p modulates epithelial-mesenchymal crosstalk in lung fibrosis by targeting IGF-1

S Li, J Geng, X Xu, X Huang, D Leng, D Jiang, J Liang… - PloS one, 2016 - journals.plos.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal fibrotic lung
disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs …

Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosis

H Liang, Y Gu, T Li, Y Zhang, L Huangfu, M Hu… - Cell death & …, 2014 - nature.com
Abstract Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and highly lethal
fibrotic lung disease with poor treatment and unknown etiology. Emerging evidence …

The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis

X Ji, B Wu, J Fan, R Han, C Luo, T Wang, J Yang… - Scientific reports, 2015 - nature.com
To identify microRNAs (miRNAs, miRs) with potential roles in lung fibrogenesis, we
performed genome-wide profiling of miRNA expression in lung tissues from a silica-induced …

MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis

S Das, M Kumar, V Negi, B Pattnaik… - American journal of …, 2014 - atsjournals.org
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive
remodeling of lungs, with no known effective treatment. Although transforming growth factor …

The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis

X Chen, C Shi, C Wang, W Liu, Y Chu, Z Xiang, K Hu… - Scientific reports, 2017 - nature.com
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal fibrotic lung disease
characterized by profound changes in stem cell differentiation, epithelial cell phenotypes …

MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation

C Huang, X Xiao, Y Yang, A Mishra, Y Liang… - Journal of Biological …, 2017 - ASBMB
Aberrant proliferation and activation of lung fibroblasts contribute to the initiation and
progression of idiopathic pulmonary fibrosis (IPF). However, the mechanisms responsible for …